Early de Novo Gene Expression Is Required for 15-Deoxy-Δ ^12,14-prostaglandin J₂-induced Apoptosis in Breast Cancer Cells

Chemical Compounds

• Prostaglandin J2 100%
• Cyclin Dependent Kinase Inhibitor 78%
• Inducer 56%
• Prostaglandin 55%
• Arachidonic Acid 53%
• Protein Synthesis 50%
• Complementary DNA 50%
• Hormone 48%
• Pharmacological Metabolism 37%
• Peptide 28%
• Ligand 21%

Medicine & Life Sciences

• 15-deoxy-delta(12,14)-prostaglandin J2 88%
• 9-deoxy-delta-9-prostaglandin D2 73%
• Breast Neoplasms 31%
• Apoptosis 29%
• Gene Expression 29%
• Peroxisome Proliferator-Activated Receptors 25%
• Fas Ligand Protein 16%
• cyclopentenone 11%
• Cyclin-Dependent Kinase Inhibitor p21 9%
• Caspase Inhibitors 8%
• Oligonucleotide Array Sequence Analysis 7%
• Cytoplasmic and Nuclear Receptors 7%
• Caspases 7%
• Arachidonic Acid 7%
• S Phase 6%
• Cell Cycle Checkpoints 6%
• Prostaglandins 6%
• Genes 5%
• Tumor Necrosis Factor-alpha 4%
• Research Personnel 4%
• RNA 4%
• Peptides 4%
• Proteins 2%
• Neoplasms 2%